IHC revealed uniform expression of CK7 and CK19 but was negative for hepatocyte antigen and Glypican-3 in tumor cells, which argues against the pathological diagnosis of HCC or combined HCC and cholangiocarcinoma. The gene discussed is KRT19; the disease is cholangiocarcinoma.